Contral Clinics Suomeksi In English
Contral Treatment
Clinical Trials
Naltrexone
Sinclair Method
Extinction

Contact us:

Novalco Oy
ContrAl Clinics
Medicity Tapiola
Länsituulentie 1 A 2. krs
02100 Espoo
Tel. +358 9 530 50 600
Fax: +358 9 530 50 660

Contact information for other Contral clinics

Services

David Sinclair

Many of the scientific and theoretical findings leading to the treatment were made by Dr. John David Sinclair (Ph.D., University of Oregon, 1972; docent, Helsinki University). Dr. Sinclair came to Finland in 1972 to work at the Biomedical Research Center of Alko. His early work was the first to demonstrate clearly that alcohol drinking produces reinforcement (Nature 249: 590-592, 1974) and that it is affected by opiates (Nature 246: 425-427, 1973). He is continuing his research currently at the National Public Health Institute (KTL) in Helsinki.

He has been granted patents in the USA, Europe, Canada, Australia, etc., on the extinction treatment for alcoholism with opiate antagonists, including naltrexone. Later discoveries from his research (e.g., selective extinction) are included also in the method now being used by ContrAl Clinics

 


Copyright 1999-2007 Contral Clinics | All rights reserved.
Legal notice and privacy statement.